Abbreviations: DON, deoxynivalenol; Drp1, dynamin-related protein 1; FD4, fluorescein isothiocyanate (FITC)-labeled dextran; HMGB1, high mobility group box-1 protein; IPEC-1, intestinal porcine epithelial cell line 1; LDH, lactate dehydrogenase; MLKL, mixed lineage kinase-like protein; PGAM5, phosphoglycerate mutase family 5; RIP1, receptor interacting protein kinase 1; RIPK3, receptor interacting protein kinase 3; TEER, transepithelial electrical resistance; TNFR1, tumor necrosis factor receptor 1. Abstract Deoxynivalenol (DON) is one of the most common mycotoxins that contaminates food or feed and cause intestinal damage. Long-chain n-3 polyunsaturated fatty acids (PUFA) such as EPA and DHA exert beneficial effects on intestinal integrity in animal models and clinical trials. Necroptosis signaling pathway plays a critical role in intestinal cell injury. This study tested the hypothesis that EPA and DHA could alleviate DON-induced injury to intestinal porcine epithelial cells through modulation of the necroptosis signaling pathway. Intestinal porcine epithelial cell 1 (IPEC-1) cells were cultured with or without EPA or DHA (6.25-25 μg/mL) in the presence or absence of 0.5 μg/mL DON for indicated time points. Cell viability, cell number, lactate dehydrogenase (LDH) activity, cell necrosis, transepithelial electrical resistance (TEER), fluorescein isothiocyanate-labeled dextran 4kDa (FD4) flux, tight junction protein distribution, and protein abundance of necroptosis related signals were determined. EPA and DHA promoted cell growth indicated by higher cell viability and cell number, and inhibited cell injury indicated by lower LDH activity in the media. EPA and DHA also improved intestinal barrier function, indicated by higher TEER and lower permeability of FD4 flux as well as increased proportions of tight junction proteins located in the plasma membrane. Moreover, EPA and DHA decreased cell necrosis demonstrated by live cell imaging and transmission electron microscopy. Finally, EPA and DHA downregulated protein expressions of necroptosis related signals including tumor necrosis factor receptor (TNFR1), receptor interacting protein kinase 1 (RIP1), RIP3, phosphorylated mixed lineage kinase-like protein (MLKL), phosphoglycerate mutase family 5 (PGAM5), dynamin-related protein 1 (Drp1), and high mobility group box-1 protein (HMGB1). EPA and DHA also inhibited protein expression of caspase-3 and caspase-8. These results suggest that EPA and DHA 2484 | XIAO et Al.
| INTRODUCTION
The intestinal tract plays an important role in the digestion and absorption of nutrients. It is also important as the first barrier against food contaminants and exogenous or endogenous antigens. [1] [2] [3] However, many factors such as stress, infection, and toxins, can lead to gut damage and barrier dysfunction, which can escalate to intestinal diseases such as inflammatory bowel diseases and necrotizing enterocolitis. 3 Deoxynivalenol (DON) is a mycotoxin that commonly contaminates food or feed. 4, 5 Ingestion of DON-contaminated food or feed leads to altered intestinal structure, 6 compromised intestinal epithelial barrier function, [7] [8] [9] and lower nutrient absorption, 10 which can lead to severe bowel disease. 4, 5 Therefore, effective nutritional approaches are urgently needed to maintain intestinal health after intake of food contaminants.
Long-chain n-3 polyunsaturated fatty acids (PUFA) including EPA [20:5(n-3)] and DHA [22:6(n-3)], which are rich in deep sea fish oil, are important in maintaining gut health in animal models and clinical trials. 11 Research has shown that n-3 PUFA play a protective role in ischemia/reperfusion-induced intestinal injury, and exert a barrier protective effect in patients with inflammatory bowel diseases and animal models of colitis. 12, 13 So, n-3 PUFA (especially EPA and DHA) have been recommended in most nutritional guidelines issued by government and health organizations. 14 Our previous study also found that fish oil (rich in EPA and DHA) alleviated the damage of intestinal structure and barrier function of lipopolysaccharide (LPS)-stressed piglets. 15 However, little research has investigated the beneficial effect of n-3 PUFA on intestinal damage induced by mycotoxin, and the underlying molecular mechanism(s) remain largely unknown.
Intestinal injury is closely related to the mode of cell death. Currently, necrosis, apoptosis, and autophagy are three main types of cell death. 16 Necroptosis is a newly discovered type of cell death with the combined features of necrosis and apoptosis, and it is driven by two core components: receptor interacting protein kinase 3 (RIPK3) and mixed lineage kinase-like protein (MLKL). 17 Recently, several studies have demonstrated that necroptosis plays an important role in tissue injury or necrosis caused by multiple factors such as ischemia reperfusion and inflammation. 18, 19 Moreover, Pierdomenico et al. 20 have shown that necroptosis was associated with enteritis in children. Therefore, nutritional interventions which impact necroptosis signaling may exert beneficial effects in attenuating intestinal injury and dysfunction.
Accordingly, we hypothesized that EPA and DHA may exert a beneficial role on intestinal cell injury and barrier function impairment by regulating the necroptosis signaling pathway. In the present study, we used DON as a model of cell injury and barrier function compromise. 9 The study used cultured intestinal porcine epithelial cell line 1 (IPEC-1), which is highly sensitive to DON. 9 2 | MATERIALS AND METHODS
| Cell culture
Intestinal porcine epithelial cell 1 cells were originally isolated from both the jejunum and ileum of a neonatal unsuckled piglet, and were kindly supplied by Dr. Guoyao Wu's laboratory (Texas A&M University). These cells were used for all experiments, and cultured in Dulbecco's Modified Eagle's Medium-F12 (DMEM, HyClone), supplemented with 5% fetal bovine serum (Sigma-Aldrich), 1% insulin-transferrinselenium(Gibco), 1% penicillin/streptomycin (Gibco), and epidermal growth factor (5 ng/mL) (Gibco). Cultures were split into 75 cm 2 culture flasks when cell monolayers reached 70%-80% confluency using trypsin/EDTA (0.25%, 0.9 mM EDTA) (Gibco). Cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 . EPA, DHA, DON, and yoyo-3 were purchased from Sigma-Aldrich Ltd.
| Cell viability assays
Cells were plated into 96-well microplates (Corning), and cell viability was detected using the Cell Counting Kit-8 detection kit (Beyotime Institute of biotechnology). After cells were cultured to 70%-80% confluency, they were first treated with 0, 6.25, 12.5, and 25 μg/mL EPA or DHA for 24 hours, and then stimulated with phosphate-buffered saline (PBS) or 0.5 μg/mL DON for 24, 48, and 72 hours. The concentration of EPA, DHA, and DON was chosen according to Willemsen et al. 21 and Diesing et al. 9 and our preliminary research. The prevent DON-induced intestinal cell injury and enhance barrier function, which is associated with inhibition of the necroptosis signaling pathway.
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absorbance was quickly measured at a wavelength of 450 nm using a microplate reader (Bio-Rad) according to the manufacturer's instructions.
| Lactate dehydrogenase (LDH) activity measurement
Cells were seeded in 12-well plates until 80% confluency and then firstly cultured with 0, 6.25, 12.5, and 25 μg/mL EPA or DHA for 24 hours, and finally treated with PBS or 0.5 μg/mL DON for another 48 hours. Subsequently, cell supernatants were collected for LDH measurement by using a LDH assay kit (Nanjing Jiancheng Institute of Bioengineering) according to the manufacturer's protocol. The absorbance was read at a wavelength of 450 nm using an automated microplate reader (Bio-Rad).
| Determination of cell number
Cells were seeded in 96-well plates, and were cultured with 0 or 12.5 μg/mL EPA or DHA for 24 hours, and then treated with PBS or 0.5 μg/mL DON for another 48 hours. Cells were then stained with trypan blue and total cell count was determined with a hemocytometer.
| Measurement of cell barrier function
Cells were seeded in a collagen-coated permeable polycarbonate membrane transwell chambers (0.4 µm pore size; Corning) at a density of 1.5 × 10 5 cells/well and grown as monolayers for 10 d prior to experiments. The cells were first cultured with 0 or 12.5 μg/mL EPA or DHA for 24 hours in the apical chamber, and then treated with PBS or 0.5 μg/mL DON for 24 and 48 hours. Transepithelial electrical resistance (TEER) was determined every 24 hours with the use of an EVOM volt-ohmmeter (Millipore). Fluorescein isothiocyanate (FITC)-labeled dextran 4 kDa (FD4, Sigma) was added to the apical chamber. Then monolayers were incubated at 37°C for 2 hours. 100 µL sample was taken from basal chamber and fluorescence was measured using a microplate reader (Bio-Tek). The permeability of monolayer cells was defined as the amount of FD4 that was transported from the apical side into the basolateral chamber.
| Confocal immunofluorescence microscopy
Cells were seeded on glass coverslips (Corning) and cultured with 0 or 12.5 μg/mL EPA or DHA for 24 hours, and then treated with PBS or 0.5 μg/mL DON for another 48 hours. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100. The cells were blocked with 1% bovine serum albumin in PBS for 30 minutes and then incubated with anti-claudin-1 (#519000, Invitrogen) antibody and ZO-1 (#abs131224, Absin) antibody overnight. Cells were then incubated with a goat anti-rabbit secondary antibody conjugated to Alexa Fluor 488 for 2 hours (Invitrogen), followed by counterstaining with 4,6-diamidino-2-phenylindole (Sigma-Aldrich). The coverslips were mounted onto glass microscope slides using mounting buffer, and visualized using a fluorescent confocal laser scanning Microscope (FV10i, Olympus). The fluorescence intensity was quantified by the Olympus flouview ver 3.1b software.
| IncuCyte ZOOM assay
Cells were seeded in 24-well plates, and were cultured with or without 12.5 μg/mL EPA or DHA in the presence or absence of 0.5 μg/mL DON in the IncuCyte ZOOM Live Cell Imaging System (Essen BioScience). The system measures cell necrosis in real time and automatically calculates the relative density of necrotic cells within the initially vacant area at each time point with the nucleic acid stain dye (yoyo-3). The observation period was 72 hours. Data were exported and analyzed by IncuCyte S3 software (Essen Bioscience).
| Transmission electron microscopy
Cells were cultured with 0 or 12.5 μg/mL EPA or DHA for 24 hours, and then treated with PBS or 0.5 μg/mL DON for another 48 hours. Cells were prepared for transmission electron microscopy (TEM) (FEI TECNAI) via conventional methods as described by He et al. 22 For quantitative analysis of necrotic cells, a total of 200 IPEC-1 cells were counted and the number of necrotic cells was recorded. Necrotic cells were defined as cells with morphology characteristics of primary necrosis (plasma membrane ruptures without nuclear condensation).
| Western blot
Cells were cultured with or without 12.5 μg/mL EPA or DHA in the presence or absence of 0.5 μg/mL DON. Cells were then harvested for analysis of abundance of proteins by Western blotting as previously described. 15 Briefly, proteins were extracted from cells, quantified, and separated by SDS-PAGE and then transferred to polyvinylidene difluoride membranes (Millipore). Membranes were then incubated with primary antibodies at 4°C overnight and then washed three times with PBS solution with 0.1% Tween-20 for 15 min. Tumor necrosis factor receptor (TNFR1) (#ab19139), phosphoglycerate mutase family 5 (PGAM5) (#ab131552), and dynamin-related protein 1 (DRP1) (#ab154879) antibodies were purchased from Abcam. Receptor interacting protein kinase 1 (RIP1) (#LS-B8214) was purchased by LifeSpan BioSciences and RIP3 (#SC-135170) antibodies were purchased from Santa Cruz Biotechnology. Caspase-3 (#9661), caspase-8 (#4927), MLKL (#37705), and anti-phospho-MLKL (#62233) antibodies were purchased from Cell Signaling Technology. High mobility group box-1 protein (HMGB1) (#PAB12414) was purchased from Abnova Corporation and β-actin (#A2228) was purchased from Sigma-Aldrich. The membranes were then incubated with an HRP-conjugated secondary antibody (Santa Cruz Biotechnology) at room temperature for 1 hour. The signal was detected with the use of the super enhanced chemiluminescence kit (Amersham). Qualification of band density was determined with the use of Quantity One software (Bio-Rad). The result was expressed as the abundance of each target protein relative to β-actin protein except for the phosphorylated MLKL which was normalized with the total protein content of MLKL.
| ROS measurement
Cells were seeded in 12-well plates and cultured with 0 or 12.5 μg/mL EPA and DHA for 24 hours before treating with PBS or 0.5 μg/mL DON for 48 hours. Then 10 μM DCFH-HA was added to each well according to the instructions of reactive oxygen species assay kit (Nanjing Jiancheng Institute of Bioengineering). ROS production was determined by flow cytometry (Mclbeckman). The average fluorescence intensity was calculated by FC 500 software.
| Statistical analysis
Data were analyzed by ANOVA using the general linear model procedures (SAS Institute). The model included the effects of DON, n-3 FUFA and their interaction terms. All data were represented as means ± SE. When significant n-3 PUFA × DON interaction occurred, multiple comparison tests was performed using Duncan's multiple comparisons. The effects of EPA or DHA levels on cell viability and LDH activity were analyzed using regression analysis. The effects of increasing EPA or DHA levels were partitioned into linear and quadratic components using orthogonal polynomial contrasts. Differences were considered significant for values of P ≤ .05.
| RESULTS

| Effects of EPA and DHA on viability of
IPEC-1 cells challenged with DON
Cells treated with DON had lower cell viability at 24 hours, 48 hours, and 72 hours (P < .05) ( Figure 1 ). There was an EPA × DON interaction observed for cell viability at 24 hours in which cell viability increased linearly and quadratically (P < .001) with increasing levels of EPA in the presence of DON. There was no EPA × DON interaction observed for cell viability at 48 hours and 72 hours. With the increased levels of EPA, cell viability was increased linearly and quadratically (P < .001). There was no DHA × DON interaction observed for cell viability at 24 hours, 48 hours, and 72 hours. Cell viability was increased linearly and quadratically (P <.001) with increasing levels of DHA.
| Effects of EPA and DHA on LDH activity in IPEC-1 cell supernatant following challenge with DON
The cells treated with DON had higher LDH activity in the supernatant at 48 hours than the control cells (P < .01) ( Figure 2 ). There was an EPA × DON interaction in which LDH activity decreased linearly (P < .05) with increasing level of EPA among DON-treated cells. A similar DHA × DON interaction was also observed in which DHA decreased LDH activity in the presence of DON (P < .01).
| Effects of EPA and DHA on cell number in IPEC-1 cells challenged with DON
Cells treated with DON had lower cell number at 48 hours (P < .001) than the cells in control group (Figure 3 ). There was no n-3 PUFA × DON interaction observed for cell number. Cells treated with EPA or DHA had higher cell number (P < .05) than cells in control group in the presence or absence of DON. EPA resulted in higher cell number (P < .01) than DHA.
| Effects of EPA and DHA on cell barrier integrity in IPEC-1 cells challenged with DON
To explore the effects of EPA and DHA on cell barrier function, we assessed cell TEER and FD4 flux in transwell inserts. Cells treated with DON had lower TEER (P < .001) than control cells at 24 hours and 48 hours ( Figure 4A ). There was an n-3 PUFA × DON interaction observed for TEER (P < .01) in which cells treated with EPA or DHA had higher TEER (P < .001) than control cells in the presence of DON, whereas TEER did not differ among PBS-treated cells. Moreover, EPA resulted in higher TEER (P < .05) than DHA at 24 hours and 48 hours.
Cells incubated with DON had higher FD4 flux ( Figure  4B ) compared with the control cells at 24 hours and 48 hours (P < .05). There was an n-3 PUFA × DON interaction observed for FD4 flux (P < .05) in which cells treated with EPA or DHA had lower FD4 flux (P < .05) than control group among DON-treated cells, whereas FD4 flux did not differ among PBS-treated cells.
| Effects of EPA and DHA on cellular distribution of tight junction proteins in IPEC-1 cells challenged with DON
To assess the distribution of tight junction proteins after EPA and DHA treatment, immunostaining was performed with a laser scanning confocal microscope. Cells treated with DON exhibited disrupted localization of claudin-1 and ZO-1 proteins at plasma membrane compared with the control cells. In contrast, EPA and DHA incubation prevented the disturbance of claudin-1 ( Figure 5A ) and ZO-1 ( Figure 5B ) proteins induced by DON and promoted the localization of claudin-1 and ZO-1 to the plasma membrane.
| Effects of EPA and DHA on cell necrosis in IPEC-1 cells challenged with DON
To explore the effect of EPA and DHA on cell necrosis, we used the IncuCyte ZOOM Live Cell Imaging System to monitor dynamic changes of cells (Supplemental videos 1-6). Cells incubated with DON had a higher number of necrotic cells than the PBS-control cells from 24 hours to 72 hours ( Figure 6A ). There was an n-3 PUFA × DON interaction observed for necrotic cell number in which cells incubated with EPA or DHA had lower cell necrosis among DON stimulation groups whereas there was no difference among PBS-treated cells. The cell necrosis was also verified by images from the system at 48 hours after DON treatment ( Figure 6B ).
To further investigate the effect of EPA and DHA on cell necrosis, we used TEM to examine ultrastructure of the cells. Compared with normal cells with intact membrane and normal nucleus, cells treated with DON exhibited distressed features such as ruptured cell membranes, disturbed cytoplasm, and chromatin, apoptotic bodies in the cytoplasm, severely vacillated mitochondria and unclear endoplasmic reticulum ( Figure 7A ). We further counted the necrosis cell number in the TEM. Consistently, cells treated with DON had higher cell necrosis ratio than the control cells (P < .001) ( Figure 7B ). There was an n-3 PUFA × DON interaction observed for cell necrosis ratio (P < .05) in which cells incubated with EPA or DHA had lower cell necrosis ratio (P < .001) at 48 hours among DON stimulation groups whereas cell necrosis ratio did not differ among PBS-treated cells.
| Effects of EPA and DHA on necroptosis signals in IPEC-1 cells challenged with DON
To examine the involvement of the necroptosis signaling pathway in the beneficial effects of EPA and DHA, we next measured the protein expression of key signaling molecules in this pathway by immunoblotting. There was no n-3 PUFA × DON interaction observed for TNFR1, RIP1, RIP3, and Drp1 protein expression. Cells treated with DON had higher TNFR1 (P < .001), RIP3 (P < .01), MLKL phosphorylation (P < .01), DRP1 (P < .05), and HMGB1 expression (P = .05) than the control cells. Rather, EPA or DHA decreased the TNFR1 (P < .01), RIP1 (P < .05), RIP3 (P < .05), and Drp1 (P < .001) in the presence or absence of DON ( Figure 8 ). There was an n-3 PUFA × DON interaction observed for MLKL phosphorylation (P < .01), PGAM5 (P < .01), and HMGB1 (P < .001) protein expression in which EPA or DHA decreased the protein expression of MLKL phosphorylation (P < .05), PGAM5 (P < .05), and HMGB1 (P < .01) compared with the control among DON-treated cells whereas MLKL phosphorylation and HMGB1 did not differ among PBS-treated cells.
Interestingly, cells treated with DON had higher caspase-3 (P < .001) and caspase-8 (P < .01) expression than the control cells (Figure 9 ). There was an n-3 PUFA × DON interaction (P < .05) observed for caspase-3 and caspase-8 protein expression in which cells incubated with EPA or DHA had lower protein expression of caspase-3 (P < .05) and caspase-8 (P < .001) at 48 hours among DON stimulation groups whereas caspase-3 and caspase-8 protein expression did not differ among PBS-treated cells.
| Effects of EPA and DHA on reactive oxygen species (ROS) production in IPEC-1 cells challenged with DON
Superfluous ROS may destroy the redox balance, and then damage the proteins, lipids, and DNA, eventually leading to intestinal cell injury and necrosis. 23 Cells incubated with DON had more ROS production than the control cells (P < .001) ( Figure 10 ). There was an n-3 PUFA × DON interaction (P < .01) observed for ROS production in which EPA or DHA treatment decreased the ROS production among DON-treated cells while there is no difference in ROS production among PBS-treated cells.
| DISCUSSION
N-3 PUFA such as EPA and DHA exert protective effects in patients with inflammatory bowel diseases and animal models of colitis. 24, 25 Our previous study also showed that dietary supplementation with fish oil (rich in EPA and DHA) prevented intestinal damage and protected barrier function in weaned piglets after LPS challenge. 15 Based on this, we investigated the protective effect of n-3 PUFA on intestinal cell injury and barrier function impairment after DON challenge, and to explore its molecular mechanism(s) using the IPEC-1 cell model. DON is a mycotoxin with strong cytotoxicity, which mainly exerts toxic effects in gastrointestinal tract and immune system and can lead to intestinal damage. 26 Cell viability and number serve as criteria that reflect cell growth, and amount of LDH released into the culture medium from damaged cell membranes reflects cell damage. In our study, expectedly, DON challenge decreased cell viability and cell number, and increased LDH activity, which suggested that DON caused epithelial cell damage. Our data demonstrated that EPA and DHA increased cell viability and cell number, and decreased LDH activity, which indicated that EPA and DHA improved cell growth and prevented cell injury. Similarly, DHA increased cell viability after TNF-α challenge in L929 cells, 27 and EPA improved cell survival after TNF-α challenge in murine skeletal muscle cells. 28 Our previous study also showed that dietary supplementation with fish oil (rich in EPA and DHA) increased the number of intestinal epithelial lymphocytes in weaned piglets after LPS challenge. 29 Intestinal epithelium is a physical barrier separating the internal from the external environment in animals. 30 TEER and mucosal-to-serosal flux of FD4 are indicators of epithelial cell barrier function, which refers to the permeability of intestinal epithelium. High TEER and low FD4 flux mean low intercellular permeability of the epithelium. In our study, supplementation of EPA and DHA in culture medium led to increased TEER and decreased mucosal-to-serosal flux of FD4 in intestinal epithelial cells, suggesting a beneficial role for EPA and DHA in maintaining cell barrier function. Similarly, supplementation of n-3 fatty acids, which included EPA and DHA, have been reported to effectively prevent the decrease of TEER and the elevation of FD4 flux induced by inflammatory factors. 31, 32 Moreover, EPA and DHA also supported epithelial barrier integrity in T84 cell monolayers by improving TEER and reducing IL4-mediated permeability increase. 21 The intestinal barrier mainly consists of a layer of epithelial cells joined together by tight junctions. 33 The tight junction proteins, including occludin, claudins, and zonula occludens (ZO), provide a functional structure in the intestinal epithelium. In the current experiment, consistent with improved intestinal barrier function, EPA and DHA protected protein distribution of claudin-1 and ZO-1 as measured by confocal microscopy. In accordance with our study, EPA and DHA have been reported to protect the barrier function by preventing the disruption of tight junction structure both in vivo and in vitro. 31, 34 Our previous research also found that fish oil enhanced protein expression of intestinal occludin and claudin-1 in LPS-challenged piglets. 15 In our present study, EPA and DHA may partially improve intestinal barrier Cell death contributes to intestinal injury and barrier function impairment. Thus, we further measured cell necrosis using the IncuCyte ZOOM Live Cell Imaging System, which can observe necrotic cells in real time and also automatically calculate the relative necrotic cell density within the initially vacant area at each time point. In the current study, consistent with improved intestinal cell integrity, we found that EPA or DHA supplementation decreased cell necrosis density. Furthermore, cell necrotic phenomenon was also demonstrated by TEM. Under PBS-control conditions, cells showed normal cellular morphology including intact cytoplasmic membranes and nucleus and nuclear membrane, clear endoplasmic reticulum, and intact mitochondria. Necrotic cells displayed swelling of mitochondria, unclear endoplasmic reticulum, nuclear condensation, chromatin extravasation as well as discontinuous cytoplasmic membranes, and appearance of apoptosomes. In our experiment, consistent with the results measured by the IncuCyte ZOOM Live Cell Imaging System, EPA, and DHA supplementation decreased the percentage of necrotic cells. Although the beneficial effect of n-3 PUFA on intestinal health has been studied, the research on n-3 PUFA regulating cell necrosis is very limited. Only a report from Kishida et al. showed that DHA enrichment reduced L929 cell necrosis induced by TNF-α. 35 These results indicate a novel and important role for n-3 PUFA in inhibiting cell necrosis.
To elucidate the molecular mechanism(s) by which EPA and DHA might attenuate intestinal cell necrosis, we examined the role of the necroptosis signaling pathway. Necroptosis is an increasingly appreciated pathway of regulated necrosis. Various stimuli, including TNF family members, Fas ligand, LPS, TLRs, and retinoic acid-inducible gene I (RIG-I) like receptors can initiate the necroptosis pathway. 36, 37 Once triggered by TNF-α, receptor TNFR1 induces the transient formation of a primary complex, known as complex I and then further forms complex II in the cytoplasm, which initiates necrosis of cells. The formation of a complex containing RIP kinases (RIP1 and 3) is central to this pathway. 38 Extracellular ligands trigger the formation of an RIP1/RIP3 molecular complex. Formation of this intracellular molecular complex activates MLKL via phosphorylation. Translocation of phosphorylated MLKL to the cell membrane results in the downstream programmed necroptosis. 39 In addition, the RIP1/RIP3/MLKL necrosome has been proposed to activate PGAM5 and phosphorylated PGAM5 recruits the mitochondrial fission factor Drp1 and activates its GTPase activity by dephosphorylating the serine site of Drp1. Drp1 activation causes mitochondrial fragmentation and ROS generation, which finally leads to cell necroptosis. 40, 41 Necrotic cells release HMGB1 outside the cells. Several studies have F I G U R E 8 Effect of EPA and DHA on protein expression of necroptosis signals after DON challenge in IPEC-1 cells. Cells were preincubated with 0 or 12.5 μg/mL EPA or DHA for 24 hours and then treated with PBS or 0.5 μg/mL DON for 48 hours. Values are means ± SE, n = 6. abc Means without a common letter differ, P < .05. IPEC-1, intestinal porcine epithelial cell 1; TNFR1, tumor necrosis factor receptor; RIP1, receptor interacting protein 1; RIP3, receptor interacting protein 3; MLKL, mixed lineage kinase domain like-domain protein; PGAM5, phosphoglycerate mutase family 5; Drp1, dynamin-related protein 1; HMGB1, high mobility group box-1 protein; DON, deoxynivalenol demonstrated that necroptosis was involved in dysfunction of intestinal epithelium cells. 42, 43 In the present study, we observed that protein expression of TNFR1, RIP1, RIP3, and p-MLKL, PGAM5, DRP1, and HMGB1 was decreased in cells pretreated with EPA or DHA after DON challenge. In addition, we also observed that DON challenge increased the ROS production and EPA and DHA treatment decreased ROS production after DON challenge, which is consistent with the decreased cell necrosis in IPEC-1 cells. Our results are supported by Bodea et al. 44 who reported DON influenced the oxidative status and improved the ROS production in HepG2 cells and the findings that dietary EPA and DHA alleviated ischemia/reperfusion-induced intestinal injury by improving the oxidative stress enzyme machinery, ie, superoxide dismutase and catalase. 45 Until now, there are no studies to investigate the effect of n-3 PUFA on necroptosis. It is possible the protective effects of EPA and DHA supplementation on cell injury and barrier function impairment were closely related to reducing cell necroptosis through inhibiting the necroptosis signaling pathway. These results indicate a novel mechanism for n-3 PUFA in maintaining intestinal cell integrity.
Interestingly, in the currently study, we also observed that protein abundances of caspase-3 and caspase-8 were decreased in EPA and DHA supplemented cells after DON challenge. However, it is traditionally thought that necroptosis is activated when caspase-8 is inhibited. Research from Marjan et al. 46 showed that EPA and DHA alleviated cell apoptosis induced by ischemia-reperfusion in rat kidneys cells. The research on n-3 PUFA regulating apoptosis and necroptosis signaling is very limited. Günther et al. reported that caspase-8 played a critical function in regulating F I G U R E 9 Effect of EPA and DHA on protein expression of apoptosis signals in IPEC-1 cells challenged with DON. Cells were preincubated with 0 or 12.5 μg/mL EPA or DHA for 24 hours and then treated with PBS or 0.5 μg/mL DON for 48 hours. Values are means ± SE, n = 6. ab Means without a common letter differ, P < .05. IPEC-1, intestinal porcine epithelial cell 1; DON, deoxynivalenol F I G U R E 1 0 Effect of EPA and DHA on ROS generation after DON challenge in IPEC-1 cells. Cells were preincubated with 12.5 μg/ mL EPA or DHA for 24 hours and then treated with PBS or 0.5 μg/mL DON for 48 hours. Values are means ± SE, n = 6. abc Means without a common letter differ, P < .05. IPEC-1, intestinal porcine epithelial cell 1; ROS, reactive oxygen species; DON, deoxynivalenol intestinal homeostasis and in protecting intestinal epithelial cells from TNF-α-induced necroptotic cell death. 43 In our study, it is possible that the protective effects of EPA and DHA on intestinal cell injury are also related to inhibition of the apoptosis signaling pathway.
In summary, EPA and DHA supplementation prevents intestinal cell injury and improves epithelial barrier integrity when challenged with mycotoxin. It is possible that the protective effects of EPA and DHA on epithelial cells are closely related to reducing cell necroptosis via inhibition of necroptosis signaling pathway. Our novel findings are expected to provide a hitherto unrecognized molecular basis for dietary supplementation with n-3 PUFA to improve intestinal health in neonatal mammals, including piglets and human infants.
